Recruiting

Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(5 sites)

China

The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang

People's Hospital of Qihe County, Dezhou, Shandong

Liaocheng People's Hospital（Liaocheng Brain Hospital）, Liaocheng, Shandong

Third People's Hospital of Liaocheng, Liaocheng, Shandong

Yantai Penglai traditional Chinese medicine hospital, Yantai, Shandong